MeMed is a host response, med-tech & bioconvergence company, offering innovative diagnostic host response tests that address complex clinical dilemmas & improve patient outcomes.
Location: Israel, Haifa District, Haifa
Total raised: $176.2M
Investors 3
| Date | Name | Website |
| - | Western Te... | westerntec... |
| 03.08.2023 | Shavit Cap... | shavitcapi... |
| - | Social Cap... | socialcapi... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 20.09.2018 | - | $70M | - |
| 07.02.2018 | - | $4M | - |
| 26.04.2017 | - | $9.2M | - |
| - | - | $93M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 07.12.2021 | Lighting Up The World: The Game-Changing Technologies That W... | Nine prominent Israeli tech companies presented their world-changing technologies to UN ambassadors ... | forbes.com... |
| 02.06.2020 | OurCrowd launches $100M Pandemic Innovation Fund to invest i... | OurCrowd, a Jerusalem, Israel-based venture capital firm and the world’s largest crowdfunded-venture... | techstartu... |
| 13.02.2020 | Interested in Investing in Early Stage Firms? OurCrowd Has a... | OurCrowd is arguably the leading investment crowdfunding platform in the world. Based in Israel but ... | crowdfundi... |
| 07.03.2019 | Global Investment Platform OurCrowd Tops $1 Billion Raised, ... | OurCrowd, the largest investment crowdfunding platform in the world, has topped $1 billion in fundin... | crowdfundi... |
| 07.03.2019 | OurCrowd Offers New $50 Million Medtech Fund for Investors | OurCrowd, the largest investment crowdfunding platform in the world, has announced the launch of the... | crowdfundi... |
| 25.09.2018 | Term Sheet — Tuesday, September 25 | THE KING OF PRODUCTIVITY Good morning, Term Sheet readers. Paid Content You can't secure what you ... | fortune.co... |
| 20.09.2018 | MeMed Raises Over $70M in Financing Roun | MeMed, a Haifa, Israel-based developer of point-of-care platform and immune-based test for distingui... | finsmes.co... |
| 07.02.2018 | MeMed Secures $4M Funding From the Department of Defense | MeMed Ltd., a Tirat Carmel, Israel-based provider of a point of care platform that distinguishes bac... | finsmes.co... |
| 26.04.2017 | MeMed gets $9.2M to develop tools to distinguish between bac... | The ultimate goal is to right-size antibiotic use. All too often, patients receive antibiotics for v... | medcitynew... |
| 10.04.2015 | Is it a virus or a bacteria? New test may help curb unnecess... | A 1,000 patient trial in Israel, published in March in PLOS ONE, found that the test had a specifici... | medcitynew... |
Show more